MYC and Burkitt lymphoma: BFL-1/A1 is overexpressed in therapy-resistant lymphoma cell lines, and its expression enhances the survival of c-MYC-dependent B-cell lymphomas and EBV LMP1 protein-expressing Burkitt lymphoma [185,186,187,188].